P2Y12 inhibitors
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for P2Y12 inhibitors, covering 2015-06-09 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Monotherapy With P2Y12 Inhibitors in Patients With Atrial fIbrillation Undergoing Supraflex Stent Implantation [Phase 4]